An analysis of COVID-19-associated deaths in Primorsky Krai
https://doi.org/10.34215/1609-1175-2023-2-54-59
Abstract
Objective. To assess factors in COVID-19-associated lethal outcomes and to identify gaps in the quality of inpatient medical care.
Materials and methods. An analysis of expert opinions (reports of medical care quality) was carried out using a random sample of 116 medical histories of COVID-19-associated lethal outcomes from various hospitals in Primorsky Krai for the period from June 2020 to August 2021.
Results. The highest mortality was observed among patients aged 60–79 (53.4%) and 80–96 (30.2%). The lethal outcome occurred, on average, on the 12.8 ± 1.3 day of illness. Concomitant chronic pathologies of various organs and systems was observed in 96.5% of the deceased, with the majority of such patients having had comorbidities of three or more body systems (55.2%). Discrepancies in clinical and pathoanatomic diagnoses were noted in nine cases (7.8%) and were related to the structure of the clinical diagnosis and the reassessment of COVID-19 complications. The immediate cause of death in 84.5% of patients was acute respiratory distress syndrome.
Conclusion. Elderly and senile patients with comorbid diseases are at highest risk of severe and lethal COVID-19 outcome. The difficulty of managing such patients is associated with the complexity of diagnosis, interpretation of critical conditions, and selection of appropriate therapy.
About the Authors
V. A. Ivanis
Pacific State Medical University
Russian Federation
Russian Federation
Vladivostok
A. F. Popov
Pacific State Medical University; Far Eastern Federal University; Far Eastern Branch of the State Research and Testing Institute of Military Medicine
Russian Federation
Russian Federation
Alexander F. Popov - Dr. Sci. (Med.)., Professor, Professor of the Department of Epidemiology and Military Epidemiology, Pacific State Medical University
2, Ostryakova Ave., Vladivostok, 690002; phone: +7 (914) 704-56-20
References
1. Akimkin VG., Popova AYu., Khafizov KF. COVID-19: the evolution of the pandemic in Russia. Сommunication II: Dynamics of circulation of SARS-CoV-2 virus genovariants. Journal of Microbiology, Epidemiology and Immunobiology. 2022;99(4):381–96 (In Russ.). doi: 10.36233/0372-9311-295
2. Smirnova MS., Smirnov AV., Smirnova AV. Analysis of deaths according to the data of a covidhospital. Clinical Medicine (Russian Journal). 2022;4–5:214–20 (In Russ.). doi: 10.30629/0023-2149-2022-100-4-5-214-220
3. Abdurakhmanov IU., Umurzakov ShE., Zhamilova GK. COVID-19 and comorbid pathology (literature review). The Scientific Heritage. 2021;68(2):56– 64 (In Russ.). doi: 10.24412/9215-0365-2021-68-2-56-64
4. Ter-Baghdasaryan LV., Ratnikova LI., Sychugov GV. Description of the clinical picture of COVID-19 in patients with fatal outcome. Infectious Diseases: News, Opinions, Training. 2022;11(3):52–60 (In Russ.). doi: 10.33029/2305-34962022-11-3-52-60
5. Pshenichnaya NY., Veselova EI., Semenova DA. COVID-19 is a new global threat to humanity. Epidemiology and Infectious Diseases. 2020;1:6–13 (In Russ.). doi: 10.18565/epidem.2020.10.1.6-13
6. Arutyunov GP., Koziolova NA., Tarlovskaya EI. The agreed position of experts of the Eurasian Association of Therapists on some new mechanisms of pathogenesis of COVID-19: focus on hemostasis, issues of hemotransfusion and the system of transport of blood gases. Cardiology. 2020;5:9–19 (In Russ.). doi: 10.18087/cardio.2020.5.n1132
7. Kostinov MP. Immunopathogenic properties of SARS-COV-2 as a basis for the choice of pathogenetic therapy. Immunology. 2020;1:83–91 (In Russ.). doi: 10.33029/0206-4952-2020-41-1-83-91
8. Voitenkov VB., Marchenko NV., Skripchenko NV. The importance of instrumental methods in the diagnosis of pneumonia in coronavirus infection. Consilium Medicum. Pediatrics. 2020;1:20–5 (In Russ.). doi: 10.26442/26586630.2020.1.200120
9. Mareev YuV., Mareev VYu. The role of age, concomitant diseases and activity of the reninangiotensin-aldosterone system in COVID-19 manifestations. Effects of ACE inhibitors and angiotensin receptor blockers. Cardiology. 2020;4:4–9 (In Russ.). doi: 10.18087/cardio.2020.4.n1122
10. Chepurnaya AN., Lehmus TY. Treatment of a new coronavirus infection. Intuition or standard? Clinical Medicine. 2022;100(2–3):133–6 (In Russ.). doi: 10.30629/00232149-2022-100-2-3-133-136
Review
For citations:
Ivanis V.A., Popov A.F. An analysis of COVID-19-associated deaths in Primorsky Krai. Pacific Medical Journal. 2023;(2):54-59. (In Russ.) https://doi.org/10.34215/1609-1175-2023-2-54-59
Views:
430
Email this article 